MedTrace Logo

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

NCT05428358 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-04-29

No results posted yet for this study

Summary

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Preoperative MRI

Preoperative MRI performed between outpatient visit at the surgical clinic and scheduled date of resection

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Frank Mortensen, MD, DMSc · Aarhus University Hospital

  • Jakob Kirkegård, MD, PhD · Aarhus University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2027-12-01
Completion
2028-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05428358 on ClinicalTrials.gov